All market verdicts

LLY UP market verdict | Ezbrisk

Published: 1785949814943

Anomaly score: 2.359398154787508

Confidence: 0.75

Market summary

Lilly beats and raises again

Ezbrisk assessment

The stock is climbing sharply after Q2 earnings crushed estimates and management lifted full-year guidance, driven by surging demand for its weight-loss and diabetes drugs.

Sources: https://www.quiverquant.com/news/ELI+LILLY+($LLY)+Releases+Q2+2026+Earnings, https://www.prnewswire.com/news-releases/lilly-reports-second-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-continued-growth-and-pipeline-progress-302843165.html, https://www.moomoo.com/news/post/74147080/demand-for-weight-loss-drugs-continues-to-rise-driving-eli, https://www.marketscreener.com/news/earnings-flash-lly-eli-lilly-and-company-posts-q2-adjusted-eps-8-38-per-share-vs-factset-est-of-ce7f50dfdf80f623, https://www.cnbc.com/2026/08/05/eli-lilly-lly-earnings-q2-2026.html

Verdict ID: b5fcc1d9-d373-4605-82b0-10aea33eae4a